Mode
Text Size
Log in / Sign up
N/A Completed N=908 Randomized Double-blind Prevention

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

Human Papilloma Virus Vaccines · Attitude to Health
Source: ClinicalTrials.gov NCT03628885 ↗
Enrolled (actual)
908
Serious AEs
Results posted
Apr 2019
Primary outcomePrimary: Intention to Vaccinate Against HPV in the Next 12 Months — 3.49; 3.87; 4.16 score on a scale — p=<.02

Summary

The purpose of this study is to investigate mother's attitudes about vaccinating their 11-14 year old children against the human papillomavirus (HPV). Among mothers who do not plan to vaccinate their child, the investigators will assess the influence of brief videos tailored to mothers' questions and concerns. Mothers will be randomized to one of three arms: 1. General video message about vaccination; 2. General message plus a brief video addressing the mother's primary concern; or 3. General message plus videos address all of mother-indicated concerns. The outcome of interest is intention to vaccinate. Our hypothesis is that the tailored videos will lead to increased intention to vaccinate.

Outcome Measures

OutcomeResultp-value
PRIMARY
Intention to Vaccinate Against HPV in the Next 12 Months
3.49; 3.87; 4.16 <.02 sig

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Lives in one of 26 US states with lower rates of HPV vaccination (New Jersey, Virginia, West Virginia, Alabama, Florida, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Indiana, Minnesota, Ohio, Arkansas, Louisiana, New Mexico, Oklahoma, Kansas, Missouri, Montana, South Dakota, Utah, Wyoming, Idaho, Texas, Iowa)
  • Mother or female legal guardian of at least one child aged 11-14 years
  • Able to read and understand English
  • Target child must not have received any doses of HPV vaccine
  • The mother/respondent must indicate that she is not sure that she will vaccinate the target child in the next year.

Exclusion Criteria

  • Under 18 years of age
  • Not a mother or female legal guardian of at least one child ages 11-14 years
  • Not living in the United States or in one of the above designated states within the U.S.
  • Not able to understand or read English
  • Target child has already received at least 1 dose of HPV vaccine
  • The mother/respondent indicates (before the intervention) that she definitely intends to vaccinate the target child with HPV vaccine in the next year.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03628885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search